DAMAE Medical Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.67M
Latest Deal Amount
  • Investors
  • 12

DAMAE Medical General Information

Description

Developer of an in-vivo imaging technology designed to revolutionize skin cancer diagnosis. The company's technology, OCTAV is based on its proprietary technology that enables cellular-resolution imaging of the skin similar to histology, without the need for tissue excision and processing, enabling immediate and non-invasive diagnosis of skin cancers and helps dermatologists to have a deep look at the skin.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 28, Rue de Turbigo
  • 75003 Paris
  • France
+33 01 00 00 00 00

DAMAE Medical Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DAMAE Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 01-Sep-2019 $2.67M 00.000 Completed Generating Revenue
7. Seed Round 19-Apr-2017 00.000 00.000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 13-Oct-2015 00000 Completed Startup
5. Grant 05-Jul-2015 000.00 00000 Completed Startup
4. Accelerator/Incubator 05-Jun-2015 00000 Completed Startup
3. Accelerator/Incubator 24-Mar-2015 00000 00000 Completed Startup
2. Accelerator/Incubator 01-Jan-2015 Completed Startup
1. Seed Round 01-Jul-2014 Completed Startup
To view DAMAE Medical’s complete valuation and funding history, request access »

DAMAE Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an in-vivo imaging technology designed to revolutionize skin cancer diagnosis. The company's technology, OC
Diagnostic Equipment
Paris, France
20 As of 2020
00.000
0000000000 00.000

00000000

r sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000 000000000
Maidstone, United Kingdom
000.00
0.000 0000-00-00
0000000000 0 000.00

0000 000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culp
0000000000000 00000000
Cambridge, United Kingdom
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DAMAE Medical Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VivoSight Venture Capital-Backed Maidstone, United Kingdom 000.00 0000000000 0 000.00
0000 000000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Amsterdam, Netherlands 00 0000 0000000000 0 0000
To view DAMAE Medical’s complete competitors history, request access »

DAMAE Medical Executive Team (3)

Name Title Board Seat Contact Info
Anaïs Barut Co-Founder, Chief Executive Officer & President
David Siret Co-Founder & Chief Technology Officer
Arnaud Dubois Co-Founder & Chief Scientific Officer
To view DAMAE Medical’s complete executive team members history, request access »

DAMAE Medical Board Members (1)

Name Representing Role Since
Philippe Peltier Kurma Partners Board Member 000 0000
To view DAMAE Medical’s complete board members history, request access »

DAMAE Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DAMAE Medical Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Idinvest Partners PE/Buyout Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
News Invest Corporation Minority 000 0000 000000 0
Paris-Saclay Seed Fund Venture Capital Minority 000 0000 000000 0
Partech Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »